Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06735833
NA

MMA Embolization for Refractory Chronic Migraine

Sponsor: Cerenovus, Part of DePuy Synthes Products, Inc.

View on ClinicalTrials.gov

Summary

This is a prospective, multi-center, feasibility study to investigate safety and effectiveness of TRUFILL n-BCA liquid embolic system in bilateral middle meningeal artery (MMA) embolization for the treatment of refractory chronic migraine.

Official title: Feasibility Study to Evaluate the Initial Safety and Effectiveness of TRUFILL n-BCA Liquid Embolic System in Middle Meningeal Artery Embolization for the Preventive Treatment of Refractory Chronic Migraine

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

70

Start Date

2025-04-23

Completion Date

2029-05-15

Last Updated

2026-03-13

Healthy Volunteers

No

Conditions

Interventions

DEVICE

Middle Meningeal Artery embolization

Bilateral middle meningeal artery embolization using TRUFILL n-BCA liquid embolic system

Locations (7)

Hartford Hospital

Hartford, Connecticut, United States

University of Buffalo Medical Center

Buffalo, New York, United States

Mount Sinai

New York, New York, United States

Stony Brook University Medical Center

Stony Brook, New York, United States

Thomas Jefferson University Hospital

Philadelphia, Pennsylvania, United States

Semmes Murphey Foundation

Memphis, Tennessee, United States

West Virginia University

Morgantown, West Virginia, United States